Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) Stock Competitors & Peer Comparison
See LABU's competitors and their performance on the AMEX and across the wider stock market.
Peer Comparison Table: Asset Management - Leveraged Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for LABU and its AMEX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LABU | $214.83 | -1.70% | 1.1B | N/A | N/A | +0.42% |
| FFEU | $90.85 | +0.48% | 212.8B | N/A | N/A | N/A |
| GRAG | $4.51 | +0.52% | 97.7B | N/A | N/A | N/A |
| LACG | $2.86 | -8.40% | 83.7B | N/A | N/A | N/A |
| VTAPX | $24.33 | -0.12% | 74.6B | N/A | N/A | N/A |
| VFSUX | $10.15 | -0.29% | 54.6B | 60.05 | $0.17 | N/A |
| VFSTX | $10.15 | -0.29% | 54.6B | 60.05 | $0.17 | N/A |
| VSBSX | $19.19 | -0.16% | 33.5B | N/A | N/A | N/A |
| TQQQ | $57.68 | -3.67% | 32.7B | 26.34 | $2.19 | +0.84% |
| VWSTX | $15.78 | -0.19% | 19.2B | N/A | N/A | N/A |
Stock Comparison
Barclays ETN+ FI Enhanced Europe 50 ETN Series C (AMEX: FFEU)
LABU vs FFEU Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, FFEU has a market cap of 212.8B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while FFEU trades at $90.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas FFEU's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to FFEU's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to FFEU. This indicates higher risk in terms of short-term price fluctuations for LABU.Check FFEU's competition here
Leverage Shares 2x Long GRAB Daily ETF (NASDAQ: GRAG)
LABU vs GRAG Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, GRAG has a market cap of 97.7B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while GRAG trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas GRAG's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to GRAG's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to GRAG. This indicates higher risk in terms of short-term price fluctuations for LABU.Check GRAG's competition here
Leverage Shares 2x Long LAC Daily ETF (NASDAQ: LACG)
LABU vs LACG Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, LACG has a market cap of 83.7B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while LACG trades at $2.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas LACG's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to LACG's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to LACG. This indicates higher risk in terms of short-term price fluctuations for LABU.Check LACG's competition here
Vanguard Short-Term Inflation-Protected Securities Index Fund Admiral Shares (NASDAQ: VTAPX)
LABU vs VTAPX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, VTAPX has a market cap of 74.6B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while VTAPX trades at $24.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas VTAPX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to VTAPX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to VTAPX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check VTAPX's competition here
Vanguard Short-Term Investment-Grade Fund Admiral Shares (NASDAQ: VFSUX)
LABU vs VFSUX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, VFSUX has a market cap of 54.6B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while VFSUX trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas VFSUX's P/E ratio is 60.05. In terms of profitability, LABU's ROE is +0.00%, compared to VFSUX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to VFSUX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check VFSUX's competition here
Vanguard Short-Term Investment-Grade Fund Investor Shares (NASDAQ: VFSTX)
LABU vs VFSTX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, VFSTX has a market cap of 54.6B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while VFSTX trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas VFSTX's P/E ratio is 60.05. In terms of profitability, LABU's ROE is +0.00%, compared to VFSTX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to VFSTX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check VFSTX's competition here
Vanguard Short-Term Treasury Index Fund Admiral Shares (NASDAQ: VSBSX)
LABU vs VSBSX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, VSBSX has a market cap of 33.5B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while VSBSX trades at $19.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas VSBSX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to VSBSX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to VSBSX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check VSBSX's competition here
ProShares UltraPro QQQ (NASDAQ: TQQQ)
LABU vs TQQQ Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, TQQQ has a market cap of 32.7B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while TQQQ trades at $57.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas TQQQ's P/E ratio is 26.34. In terms of profitability, LABU's ROE is +0.00%, compared to TQQQ's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to TQQQ. This indicates lower risk in terms of short-term price fluctuations for LABU.Check TQQQ's competition here
Vanguard Ultra-Short-Term Tax-Exempt Fund Investor Shares (NASDAQ: VWSTX)
LABU vs VWSTX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, VWSTX has a market cap of 19.2B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while VWSTX trades at $15.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas VWSTX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to VWSTX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to VWSTX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check VWSTX's competition here
Direxion Daily Semiconductor Bull 3X ETF (AMEX: SOXL)
LABU vs SOXL Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, SOXL has a market cap of 15.7B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while SOXL trades at $58.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas SOXL's P/E ratio is 20.61. In terms of profitability, LABU's ROE is +0.00%, compared to SOXL's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to SOXL. This indicates lower risk in terms of short-term price fluctuations for LABU.Check SOXL's competition here
American Funds Short-Term Bond Fund of America;F1 (NASDAQ: ASBFX)
LABU vs ASBFX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, ASBFX has a market cap of 13.1B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while ASBFX trades at $9.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas ASBFX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to ASBFX's ROE of +0.10%. Regarding short-term risk, LABU is more volatile compared to ASBFX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check ASBFX's competition here
PIMCO Funds Short Term Fund Institutional Shares (NASDAQ: PTSHX)
LABU vs PTSHX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, PTSHX has a market cap of 11.5B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while PTSHX trades at $9.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas PTSHX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to PTSHX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to PTSHX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check PTSHX's competition here
ProShares - Ultra QQQ (AMEX: QLD)
LABU vs QLD Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, QLD has a market cap of 9.7B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while QLD trades at $79.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas QLD's P/E ratio is 26.54. In terms of profitability, LABU's ROE is +0.00%, compared to QLD's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to QLD. This indicates higher risk in terms of short-term price fluctuations for LABU.Check QLD's competition here
ProShares - Ultra S&P500 (AMEX: SSO)
LABU vs SSO Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, SSO has a market cap of 7.1B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while SSO trades at $67.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas SSO's P/E ratio is 26.42. In terms of profitability, LABU's ROE is +0.00%, compared to SSO's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to SSO. This indicates higher risk in terms of short-term price fluctuations for LABU.Check SSO's competition here
JPMorgan Short Duration Core Plus Fund Class A (NASDAQ: JSDHX)
LABU vs JSDHX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, JSDHX has a market cap of 6.6B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while JSDHX trades at $9.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas JSDHX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to JSDHX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to JSDHX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check JSDHX's competition here
Direxion Daily S&P 500 Bull 3X Shares (AMEX: SPXL)
LABU vs SPXL Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, SPXL has a market cap of 6.4B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while SPXL trades at $265.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas SPXL's P/E ratio is 25.23. In terms of profitability, LABU's ROE is +0.00%, compared to SPXL's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to SPXL. This indicates higher risk in terms of short-term price fluctuations for LABU.Check SPXL's competition here
Vanguard Short-Term Treasury Fund Investor Shares (NASDAQ: VFISX)
LABU vs VFISX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, VFISX has a market cap of 5.6B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while VFISX trades at $9.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas VFISX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to VFISX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to VFISX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check VFISX's competition here
Direxion Daily Technology Bull 3X ETF (AMEX: TECL)
LABU vs TECL Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, TECL has a market cap of 5.1B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while TECL trades at $141.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas TECL's P/E ratio is 27.45. In terms of profitability, LABU's ROE is +0.00%, compared to TECL's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to TECL. This indicates lower risk in terms of short-term price fluctuations for LABU.Check TECL's competition here
Direxion Daily TSLA Bull 2X ETF (NASDAQ: TSLL)
LABU vs TSLL Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, TSLL has a market cap of 4.8B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while TSLL trades at $10.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas TSLL's P/E ratio is 86.42. In terms of profitability, LABU's ROE is +0.00%, compared to TSLL's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to TSLL. This indicates lower risk in terms of short-term price fluctuations for LABU.Check TSLL's competition here
Vanguard Short-Term Federal Fund Admiral Shares (NASDAQ: VSGDX)
LABU vs VSGDX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, VSGDX has a market cap of 4.4B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while VSGDX trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas VSGDX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to VSGDX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to VSGDX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check VSGDX's competition here
Vanguard Short-Term Federal Fund Investor Shares (NASDAQ: VSGBX)
LABU vs VSGBX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, VSGBX has a market cap of 4.4B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while VSGBX trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas VSGBX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to VSGBX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to VSGBX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check VSGBX's competition here
ProShares - UltraPro S&P500 (AMEX: UPRO)
LABU vs UPRO Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, UPRO has a market cap of 4.3B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while UPRO trades at $138.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas UPRO's P/E ratio is 25.42. In terms of profitability, LABU's ROE is +0.00%, compared to UPRO's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to UPRO. This indicates higher risk in terms of short-term price fluctuations for LABU.Check UPRO's competition here
Fidelity Leveraged Company Stock Fund (NASDAQ: FLVCX)
LABU vs FLVCX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, FLVCX has a market cap of 3.6B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while FLVCX trades at $39.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas FLVCX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to FLVCX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to FLVCX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check FLVCX's competition here
Direxion Daily Semiconductor Bear 3X ETF (AMEX: SOXS)
LABU vs SOXS Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, SOXS has a market cap of 3.1B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while SOXS trades at $50.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas SOXS's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to SOXS's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to SOXS. This indicates lower risk in terms of short-term price fluctuations for LABU.Check SOXS's competition here
GraniteShares 2x Long NVDA Daily ETF (NASDAQ: NVDL)
LABU vs NVDL Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, NVDL has a market cap of 2.4B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while NVDL trades at $17.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas NVDL's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to NVDL's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to NVDL. This indicates lower risk in terms of short-term price fluctuations for LABU.Check NVDL's competition here
Direxion Daily Financial Bull 3X ETF (AMEX: FAS)
LABU vs FAS Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, FAS has a market cap of 2.2B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while FAS trades at $181.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas FAS's P/E ratio is 17.42. In terms of profitability, LABU's ROE is +0.00%, compared to FAS's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to FAS. This indicates higher risk in terms of short-term price fluctuations for LABU.Check FAS's competition here
Diamond Hill Long Short Fund Class I (NASDAQ: DHLSX)
LABU vs DHLSX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, DHLSX has a market cap of 2.2B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while DHLSX trades at $32.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas DHLSX's P/E ratio is 19.07. In terms of profitability, LABU's ROE is +0.00%, compared to DHLSX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to DHLSX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check DHLSX's competition here
PIMCO Short Asset Investment Fund Class A (NASDAQ: PAIAX)
LABU vs PAIAX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, PAIAX has a market cap of 2.2B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while PAIAX trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas PAIAX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to PAIAX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to PAIAX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check PAIAX's competition here
MicroSectors Solactive FANG & Innovation 3X Leveraged ETN (AMEX: BULZ)
LABU vs BULZ Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, BULZ has a market cap of 2.1B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while BULZ trades at $24.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas BULZ's P/E ratio is 24.03. In terms of profitability, LABU's ROE is +0.00%, compared to BULZ's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to BULZ. This indicates lower risk in terms of short-term price fluctuations for LABU.Check BULZ's competition here
MicroSectors FANG+ Index -3X Inverse Leveraged ETN (AMEX: FNGD)
LABU vs FNGD Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, FNGD has a market cap of 2B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while FNGD trades at $31.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas FNGD's P/E ratio is 23.65. In terms of profitability, LABU's ROE is +0.00%, compared to FNGD's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to FNGD. This indicates higher risk in terms of short-term price fluctuations for LABU.Check FNGD's competition here
MicroSectors FANG+ 3 Leveraged ETNs (AMEX: FNGU)
LABU vs FNGU Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, FNGU has a market cap of 2B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while FNGU trades at $24.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas FNGU's P/E ratio is 1.80. In terms of profitability, LABU's ROE is +0.00%, compared to FNGU's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to FNGU. This indicates lower risk in terms of short-term price fluctuations for LABU.Check FNGU's competition here
Diamond Hill Long Short Fund Class C (NASDAQ: DHFCX)
LABU vs DHFCX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, DHFCX has a market cap of 1.9B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while DHFCX trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas DHFCX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to DHFCX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to DHFCX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check DHFCX's competition here
Direxion Daily Small Cap Bull 3X ETF (AMEX: TNA)
LABU vs TNA Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, TNA has a market cap of 1.9B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while TNA trades at $55.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas TNA's P/E ratio is 17.28. In terms of profitability, LABU's ROE is +0.00%, compared to TNA's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to TNA. This indicates higher risk in terms of short-term price fluctuations for LABU.Check TNA's competition here
Direxion Daily 20+ Year Treasury Bull 3X ETF (AMEX: TMF)
LABU vs TMF Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, TMF has a market cap of 1.8B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while TMF trades at $27.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas TMF's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to TMF's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to TMF. This indicates higher risk in terms of short-term price fluctuations for LABU.Check TMF's competition here
ProShares - UltraPro Short QQQ (NASDAQ: SQQQ)
LABU vs SQQQ Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, SQQQ has a market cap of 1.6B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while SQQQ trades at $42.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas SQQQ's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to SQQQ's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to SQQQ. This indicates lower risk in terms of short-term price fluctuations for LABU.Check SQQQ's competition here
VelocityShares 3x Inverse Crude Oil ETNs linked to the S&P GSCI Crude Oil Index ER New (AMEX: DWT)
LABU vs DWT Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, DWT has a market cap of 1.6B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while DWT trades at $14.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas DWT's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to DWT's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to DWT. This indicates higher risk in terms of short-term price fluctuations for LABU.Check DWT's competition here
Leverage Shares 2x Long DUOL Daily ETF (NASDAQ: DUOG)
LABU vs DUOG Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, DUOG has a market cap of 1.4B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while DUOG trades at $63.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas DUOG's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to DUOG's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to DUOG. This indicates lower risk in terms of short-term price fluctuations for LABU.Check DUOG's competition here
T. Rowe Price Short-Intermediate Municipal Bond Fund (NASDAQ: PRFSX)
LABU vs PRFSX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, PRFSX has a market cap of 1.2B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while PRFSX trades at $5.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas PRFSX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to PRFSX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to PRFSX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check PRFSX's competition here
ProShares Ultra Semiconductors (AMEX: USD)
LABU vs USD Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, USD has a market cap of 1.1B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while USD trades at $54.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas USD's P/E ratio is 24.59. In terms of profitability, LABU's ROE is +0.00%, compared to USD's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to USD. This indicates lower risk in terms of short-term price fluctuations for LABU.Check USD's competition here
Rydex NASDAQ-100 2x Strategy Fund Class H (NASDAQ: RYVYX)
LABU vs RYVYX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, RYVYX has a market cap of 1.1B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while RYVYX trades at $732.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas RYVYX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to RYVYX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to RYVYX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check RYVYX's competition here
Rydex NASDAQ-100 2x Strategy Fund (NASDAQ: RYCCX)
LABU vs RYCCX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, RYCCX has a market cap of 1.1B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while RYCCX trades at $492.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas RYCCX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to RYCCX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to RYCCX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check RYCCX's competition here
Rydex NASDAQ-100 2x Strategy Fund (NASDAQ: RYVLX)
LABU vs RYVLX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, RYVLX has a market cap of 1.1B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while RYVLX trades at $732.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas RYVLX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to RYVLX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to RYVLX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check RYVLX's competition here
Calamos Phineus Long Short Fund Class A (NASDAQ: CPLSX)
LABU vs CPLSX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, CPLSX has a market cap of 1B. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while CPLSX trades at $17.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas CPLSX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to CPLSX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to CPLSX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check CPLSX's competition here
BlackRock Short Obligations Investor A (NASDAQ: BASOX)
LABU vs BASOX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, BASOX has a market cap of 961.6M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while BASOX trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas BASOX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to BASOX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to BASOX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check BASOX's competition here
Direxion Daily Regional Banks Bull 3X ETF (AMEX: DPST)
LABU vs DPST Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, DPST has a market cap of 935.1M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while DPST trades at $122.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas DPST's P/E ratio is 11.08. In terms of profitability, LABU's ROE is +0.00%, compared to DPST's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to DPST. This indicates higher risk in terms of short-term price fluctuations for LABU.Check DPST's competition here
Tradr 2X Short TSLA Daily ETF (NASDAQ: TSLQ)
LABU vs TSLQ Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, TSLQ has a market cap of 913.2M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while TSLQ trades at $14.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas TSLQ's P/E ratio is 32.69. In terms of profitability, LABU's ROE is +0.00%, compared to TSLQ's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to TSLQ. This indicates lower risk in terms of short-term price fluctuations for LABU.Check TSLQ's competition here
Direxion Daily MU Bull 2X ETF (NASDAQ: MUU)
LABU vs MUU Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, MUU has a market cap of 912.6M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while MUU trades at $17.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas MUU's P/E ratio is 13.53. In terms of profitability, LABU's ROE is +0.00%, compared to MUU's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to MUU. This indicates lower risk in terms of short-term price fluctuations for LABU.Check MUU's competition here
ProShares - Short S&P500 (AMEX: SH)
LABU vs SH Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, SH has a market cap of 891M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while SH trades at $32.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas SH's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to SH's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to SH. This indicates higher risk in terms of short-term price fluctuations for LABU.Check SH's competition here
GraniteShares 2x Long AMD Daily ETF (NASDAQ: AMDL)
LABU vs AMDL Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, AMDL has a market cap of 865.8M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while AMDL trades at $51.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas AMDL's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to AMDL's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to AMDL. This indicates lower risk in terms of short-term price fluctuations for LABU.Check AMDL's competition here
ProShares - UltraPro Dow30 (AMEX: UDOW)
LABU vs UDOW Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, UDOW has a market cap of 860.4M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while UDOW trades at $66.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas UDOW's P/E ratio is 20.79. In terms of profitability, LABU's ROE is +0.00%, compared to UDOW's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to UDOW. This indicates higher risk in terms of short-term price fluctuations for LABU.Check UDOW's competition here
ProShares - Ultra Silver (AMEX: AGQ)
LABU vs AGQ Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, AGQ has a market cap of 846.3M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while AGQ trades at $42.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas AGQ's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to AGQ's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to AGQ. This indicates higher risk in terms of short-term price fluctuations for LABU.Check AGQ's competition here
Direxion Daily Gold Miners Index Bull 2X ETF (AMEX: NUGT)
LABU vs NUGT Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, NUGT has a market cap of 832.9M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while NUGT trades at $122.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas NUGT's P/E ratio is 14.27. In terms of profitability, LABU's ROE is +0.00%, compared to NUGT's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to NUGT. This indicates higher risk in terms of short-term price fluctuations for LABU.Check NUGT's competition here
ProShares - Ultra Financials (AMEX: UYG)
LABU vs UYG Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, UYG has a market cap of 825M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while UYG trades at $99.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas UYG's P/E ratio is 17.35. In terms of profitability, LABU's ROE is +0.00%, compared to UYG's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to UYG. This indicates higher risk in terms of short-term price fluctuations for LABU.Check UYG's competition here
Direxion Daily MSCI South Korea Bull 3X ETF (AMEX: KORU)
LABU vs KORU Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, KORU has a market cap of 794.9M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while KORU trades at $7.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas KORU's P/E ratio is 8.08. In terms of profitability, LABU's ROE is +0.00%, compared to KORU's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to KORU. This indicates lower risk in terms of short-term price fluctuations for LABU.Check KORU's competition here
Eaton Vance Short Duration Muni Opps A (NASDAQ: EXMAX)
LABU vs EXMAX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, EXMAX has a market cap of 785.7M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while EXMAX trades at $9.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas EXMAX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to EXMAX's ROE of +0.09%. Regarding short-term risk, LABU is more volatile compared to EXMAX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check EXMAX's competition here
Eaton Vance Short Duration Municipal Opportunities Fund (NASDAQ: EMAIX)
LABU vs EMAIX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, EMAIX has a market cap of 785.7M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while EMAIX trades at $9.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas EMAIX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to EMAIX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to EMAIX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check EMAIX's competition here
Direxion Daily MSFT Bull 2X Shares (NASDAQ: MSFU)
LABU vs MSFU Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, MSFU has a market cap of 755.4M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while MSFU trades at $40.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas MSFU's P/E ratio is 40.13. In terms of profitability, LABU's ROE is +0.00%, compared to MSFU's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to MSFU. This indicates higher risk in terms of short-term price fluctuations for LABU.Check MSFU's competition here
Direxion Daily FTSE China Bull 3X Shares (AMEX: YINN)
LABU vs YINN Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, YINN has a market cap of 716.7M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while YINN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas YINN's P/E ratio is 7.05. In terms of profitability, LABU's ROE is +0.00%, compared to YINN's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to YINN. This indicates higher risk in terms of short-term price fluctuations for LABU.Check YINN's competition here
Proshares Ultra Qqq Equal Weight (NASDAQ: EQQQ)
LABU vs EQQQ Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, EQQQ has a market cap of 691.5M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while EQQQ trades at $37.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas EQQQ's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to EQQQ's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to EQQQ. This indicates higher risk in terms of short-term price fluctuations for LABU.Check EQQQ's competition here
ProShares - Ultra Technology (AMEX: ROM)
LABU vs ROM Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, ROM has a market cap of 659.3M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while ROM trades at $117.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas ROM's P/E ratio is 30.51. In terms of profitability, LABU's ROE is +0.00%, compared to ROM's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to ROM. This indicates lower risk in terms of short-term price fluctuations for LABU.Check ROM's competition here
ProShares - Short QQQ (AMEX: PSQ)
LABU vs PSQ Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, PSQ has a market cap of 647.6M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while PSQ trades at $26.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas PSQ's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to PSQ's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to PSQ. This indicates higher risk in terms of short-term price fluctuations for LABU.Check PSQ's competition here
MicroSectors FANG+ Index 2X Leveraged ETNs (AMEX: FNGO)
LABU vs FNGO Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, FNGO has a market cap of 631.4M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while FNGO trades at $128.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas FNGO's P/E ratio is 26.26. In terms of profitability, LABU's ROE is +0.00%, compared to FNGO's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to FNGO. This indicates higher risk in terms of short-term price fluctuations for LABU.Check FNGO's competition here
Direxion Daily GOOGL Bull 2X ETF (NASDAQ: GGLL)
LABU vs GGLL Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, GGLL has a market cap of 628.2M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while GGLL trades at $70.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas GGLL's P/E ratio is 11.44. In terms of profitability, LABU's ROE is +0.00%, compared to GGLL's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to GGLL. This indicates lower risk in terms of short-term price fluctuations for LABU.Check GGLL's competition here
ProShares Ultra Bloomberg Crude Oil (AMEX: UCO)
LABU vs UCO Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, UCO has a market cap of 627.2M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while UCO trades at $53.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas UCO's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to UCO's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to UCO. This indicates higher risk in terms of short-term price fluctuations for LABU.Check UCO's competition here
Guggenheim Ultra Short Duration A (NASDAQ: GIYAX)
LABU vs GIYAX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, GIYAX has a market cap of 623.5M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while GIYAX trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas GIYAX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to GIYAX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to GIYAX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check GIYAX's competition here
Boston Partners Long/Short Research Fund (NASDAQ: BPIRX)
LABU vs BPIRX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, BPIRX has a market cap of 616.3M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while BPIRX trades at $15.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas BPIRX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to BPIRX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to BPIRX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check BPIRX's competition here
ProShares - Ultra Gold (AMEX: UGL)
LABU vs UGL Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, UGL has a market cap of 614.7M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while UGL trades at $39.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas UGL's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to UGL's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to UGL. This indicates higher risk in terms of short-term price fluctuations for LABU.Check UGL's competition here
Medalist Partners Short Duration Fund - Investor Class (NASDAQ: SEMRX)
LABU vs SEMRX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, SEMRX has a market cap of 603.1M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while SEMRX trades at $9.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas SEMRX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to SEMRX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to SEMRX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check SEMRX's competition here
GraniteShares 2x Long GOOG Daily ETF (NASDAQ: GOU)
LABU vs GOU Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, GOU has a market cap of 575.7M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while GOU trades at $17.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas GOU's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to GOU's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to GOU. This indicates lower risk in terms of short-term price fluctuations for LABU.Check GOU's competition here
Direxion HCM Tactical Enhanced US ETF (AMEX: HCMT)
LABU vs HCMT Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, HCMT has a market cap of 557.2M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while HCMT trades at $38.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas HCMT's P/E ratio is 24.57. In terms of profitability, LABU's ROE is +0.00%, compared to HCMT's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to HCMT. This indicates higher risk in terms of short-term price fluctuations for LABU.Check HCMT's competition here
Direxion Monthly NASDAQ-100 Bull 2X Fund Investor Class (NASDAQ: DXQLX)
LABU vs DXQLX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, DXQLX has a market cap of 538.1M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while DXQLX trades at $115.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas DXQLX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to DXQLX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to DXQLX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check DXQLX's competition here
ProShares - Ultra Dow30 (AMEX: DDM)
LABU vs DDM Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, DDM has a market cap of 519.4M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while DDM trades at $64.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas DDM's P/E ratio is 21.30. In terms of profitability, LABU's ROE is +0.00%, compared to DDM's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to DDM. This indicates higher risk in terms of short-term price fluctuations for LABU.Check DDM's competition here
Direxion Daily PLTR Bull 2X Shares (NASDAQ: PLTU)
LABU vs PLTU Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, PLTU has a market cap of 516.9M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while PLTU trades at $43.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas PLTU's P/E ratio is 95.96. In terms of profitability, LABU's ROE is +0.00%, compared to PLTU's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to PLTU. This indicates lower risk in terms of short-term price fluctuations for LABU.Check PLTU's competition here
Direxion Daily META Bull 2X ETF (NASDAQ: METU)
LABU vs METU Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, METU has a market cap of 499.4M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while METU trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas METU's P/E ratio is 25.53. In terms of profitability, LABU's ROE is +0.00%, compared to METU's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to METU. This indicates higher risk in terms of short-term price fluctuations for LABU.Check METU's competition here
VelocityShares 3x Inverse Natural Gas ETN Linked to the S&P GSCI Natural Gas Index ER (AMEX: DGAZ)
LABU vs DGAZ Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, DGAZ has a market cap of 497.2M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while DGAZ trades at $452.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas DGAZ's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to DGAZ's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to DGAZ. This indicates lower risk in terms of short-term price fluctuations for LABU.Check DGAZ's competition here
Direxion Daily Homebuilders & Supplies Bull 3X ETF (AMEX: NAIL)
LABU vs NAIL Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, NAIL has a market cap of 492.4M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while NAIL trades at $33.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas NAIL's P/E ratio is 14.24. In terms of profitability, LABU's ROE is +0.00%, compared to NAIL's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to NAIL. This indicates higher risk in terms of short-term price fluctuations for LABU.Check NAIL's competition here
MAX S&P 500 4X Leveraged ETN (AMEX: SPYU)
LABU vs SPYU Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, SPYU has a market cap of 482.7M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while SPYU trades at $30.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas SPYU's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to SPYU's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to SPYU. This indicates lower risk in terms of short-term price fluctuations for LABU.Check SPYU's competition here
Direxion Daily TSM Bull 2X ETF (NASDAQ: TSMX)
LABU vs TSMX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, TSMX has a market cap of 479.9M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while TSMX trades at $65.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas TSMX's P/E ratio is 32.11. In terms of profitability, LABU's ROE is +0.00%, compared to TSMX's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to TSMX. This indicates lower risk in terms of short-term price fluctuations for LABU.Check TSMX's competition here
ProShares - UltraShort Bloomberg Crude Oil (AMEX: SCO)
LABU vs SCO Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, SCO has a market cap of 477.3M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while SCO trades at $19.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas SCO's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to SCO's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to SCO. This indicates higher risk in terms of short-term price fluctuations for LABU.Check SCO's competition here
GraniteShares 2x Long PLTR Daily ETF (NASDAQ: PTIR)
LABU vs PTIR Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, PTIR has a market cap of 447.1M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while PTIR trades at $16.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas PTIR's P/E ratio is 3.41. In terms of profitability, LABU's ROE is +0.00%, compared to PTIR's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to PTIR. This indicates lower risk in terms of short-term price fluctuations for LABU.Check PTIR's competition here
Direxion Daily Aerospace & Defense Bull 3X Shares (AMEX: DFEN)
LABU vs DFEN Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, DFEN has a market cap of 403.3M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while DFEN trades at $50.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas DFEN's P/E ratio is 24.89. In terms of profitability, LABU's ROE is +0.00%, compared to DFEN's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to DFEN. This indicates higher risk in terms of short-term price fluctuations for LABU.Check DFEN's competition here
Federated Hermes Short-Intermediate Municipal Fund SS Class (NASDAQ: FSHSX)
LABU vs FSHSX Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, FSHSX has a market cap of 384.8M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while FSHSX trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas FSHSX's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to FSHSX's ROE of N/A. Regarding short-term risk, LABU is more volatile compared to FSHSX. This indicates higher risk in terms of short-term price fluctuations for LABU.Check FSHSX's competition here
ProShares - UltraPro Short S&P500 (AMEX: SPXU)
LABU vs SPXU Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, SPXU has a market cap of 382.5M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while SPXU trades at $35.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas SPXU's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to SPXU's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to SPXU. This indicates higher risk in terms of short-term price fluctuations for LABU.Check SPXU's competition here
ProShares Ultra Bloomberg Natural Gas (AMEX: BOIL)
LABU vs BOIL Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, BOIL has a market cap of 379M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while BOIL trades at $18.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas BOIL's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to BOIL's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to BOIL. This indicates higher risk in terms of short-term price fluctuations for LABU.Check BOIL's competition here
MicroSectors Gold Miners 3X Leveraged ETN (AMEX: GDXU)
LABU vs GDXU Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, GDXU has a market cap of 354.9M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while GDXU trades at $71.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas GDXU's P/E ratio is 15.57. In terms of profitability, LABU's ROE is +0.00%, compared to GDXU's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to GDXU. This indicates higher risk in terms of short-term price fluctuations for LABU.Check GDXU's competition here
Direxion Daily Junior Gold Miners Index Bull 2X ETF (AMEX: JNUG)
LABU vs JNUG Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, JNUG has a market cap of 346.5M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while JNUG trades at $106.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas JNUG's P/E ratio is 12.28. In terms of profitability, LABU's ROE is +0.00%, compared to JNUG's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to JNUG. This indicates higher risk in terms of short-term price fluctuations for LABU.Check JNUG's competition here
MicroSectors U.S. Big Banks 3 Leveraged ETN (AMEX: BNKU)
LABU vs BNKU Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, BNKU has a market cap of 345M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while BNKU trades at $32.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas BNKU's P/E ratio is 10.61. In terms of profitability, LABU's ROE is +0.00%, compared to BNKU's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to BNKU. This indicates higher risk in terms of short-term price fluctuations for LABU.Check BNKU's competition here
GraniteShares 2x Long MU Daily ETF (NASDAQ: MULL)
LABU vs MULL Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, MULL has a market cap of 322.9M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while MULL trades at $11.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas MULL's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to MULL's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to MULL. This indicates lower risk in terms of short-term price fluctuations for LABU.Check MULL's competition here
UBS ETRACS Monthly Pay 2xLeveraged Mortgage REIT ETN Series B (AMEX: MRRL)
LABU vs MRRL Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, MRRL has a market cap of 308.5M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while MRRL trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas MRRL's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to MRRL's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to MRRL. This indicates lower risk in terms of short-term price fluctuations for LABU.Check MRRL's competition here
Direxion Daily S&P 500 Bear 3X ETF (AMEX: SPXS)
LABU vs SPXS Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, SPXS has a market cap of 306.2M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while SPXS trades at $25.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas SPXS's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to SPXS's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to SPXS. This indicates higher risk in terms of short-term price fluctuations for LABU.Check SPXS's competition here
Direxion Daily Small Cap Bear 3X ETF (AMEX: TZA)
LABU vs TZA Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, TZA has a market cap of 298.7M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while TZA trades at $46.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas TZA's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to TZA's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to TZA. This indicates higher risk in terms of short-term price fluctuations for LABU.Check TZA's competition here
Credit Suisse FI Large Cap Growth Enhanced ETN (AMEX: FLGE)
LABU vs FLGE Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, FLGE has a market cap of 295.1M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while FLGE trades at $809.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas FLGE's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to FLGE's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to FLGE. This indicates higher risk in terms of short-term price fluctuations for LABU.Check FLGE's competition here
ProShares - UltraShort S&P500 (AMEX: SDS)
LABU vs SDS Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, SDS has a market cap of 288.9M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while SDS trades at $55.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas SDS's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to SDS's ROE of -13.20%. Regarding short-term risk, LABU is more volatile compared to SDS. This indicates higher risk in terms of short-term price fluctuations for LABU.Check SDS's competition here
Direxion Daily AMZN Bull 2X ETF (NASDAQ: AMZU)
LABU vs AMZU Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, AMZU has a market cap of 283.3M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while AMZU trades at $37.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas AMZU's P/E ratio is 19.67. In terms of profitability, LABU's ROE is +0.00%, compared to AMZU's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to AMZU. This indicates higher risk in terms of short-term price fluctuations for LABU.Check AMZU's competition here
UBS ETRACS Monthly Pay 2xLeveraged Mortgage REIT ETN (AMEX: MORL)
LABU vs MORL Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, MORL has a market cap of 282.8M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while MORL trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas MORL's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to MORL's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to MORL. This indicates lower risk in terms of short-term price fluctuations for LABU.Check MORL's competition here
ProShares - UltraShort 20+ Year Treasury (AMEX: TBT)
LABU vs TBT Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, TBT has a market cap of 275.6M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while TBT trades at $40.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas TBT's P/E ratio is N/A. In terms of profitability, LABU's ROE is +0.00%, compared to TBT's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to TBT. This indicates higher risk in terms of short-term price fluctuations for LABU.Check TBT's competition here
ProShares - UltraPro Russell2000 (AMEX: URTY)
LABU vs URTY Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, URTY has a market cap of 268.5M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while URTY trades at $64.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas URTY's P/E ratio is 22.54. In terms of profitability, LABU's ROE is +0.00%, compared to URTY's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to URTY. This indicates higher risk in terms of short-term price fluctuations for LABU.Check URTY's competition here
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF (AMEX: GUSH)
LABU vs GUSH Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, GUSH has a market cap of 257.1M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while GUSH trades at $42.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas GUSH's P/E ratio is 12.48. In terms of profitability, LABU's ROE is +0.00%, compared to GUSH's ROE of +0.00%. Regarding short-term risk, LABU is more volatile compared to GUSH. This indicates higher risk in terms of short-term price fluctuations for LABU.Check GUSH's competition here
Direxion Daily NVDA Bull 2X ETF (NASDAQ: NVDU)
LABU vs NVDU Comparison November 2026
Direxion Daily S&P Biotech Bull 3X Shares (AMEX: LABU) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LABU stands at 1.1B. In comparison, NVDU has a market cap of 255.4M. Regarding current trading prices, LABU is priced at $214.83 on the AMEX, while NVDU trades at $70.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LABU currently has a P/E ratio of N/A, whereas NVDU's P/E ratio is 18.67. In terms of profitability, LABU's ROE is +0.00%, compared to NVDU's ROE of +0.00%. Regarding short-term risk, LABU is less volatile compared to NVDU. This indicates lower risk in terms of short-term price fluctuations for LABU.Check NVDU's competition here